Imprint Wealth’s Gilead Sciences GILD Stock Holding History
Bought
Maintained
Sold
Other funds holding GILD
Imprint Wealth's GILD Position: Q3 2026 in Review
Imprint Wealth increased its Gilead Sciences (GILD) stake by 40% in Q3 2026, buying an estimated $2.53K and bringing the position to 63 shares worth $9.39K. The position accounts for 0.03% of the portfolio, ranked #146.
Imprint Wealth first reported a position in GILD in Q3 2023 and has held it in 8 quarters since. The position peaked at $271K in Q4 2023. 2,341 funds tracked by Wall St. Rank hold GILD as of Q3 2026.
- Imprint Wealth held 63 shares of Gilead Sciences worth $9.39K as of Q3 2026.
- Imprint Wealth bought 18 Gilead Sciences shares in Q3 2026, an estimated $2.53K.
- Gilead Sciences made up 0.03% of Imprint Wealth's portfolio in Q3 2026, its #146 holding.
- Imprint Wealth first reported a position in Gilead Sciences in Q3 2023 and has held it in 8 quarters since.
- Imprint Wealth's Gilead Sciences position peaked at $271K in Q4 2023.
- 2,341 funds tracked by Wall St. Rank held Gilead Sciences as of Q3 2026.
Based on Imprint Wealth's 13F filing for Q3 2026, filed 16 Nov 2026.